Skip to main content
Print Save

The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.

Empaveli Prices, Coupons and Patient Assistance Programs

Empaveli is available as a brand name drug only, a generic version is not yet available. See generic Empaveli availability.

Empaveli (pegcetacoplan) is a member of the selective immunosuppressants drug class and is commonly used for Paroxysmal Nocturnal Hemoglobinuria.

Empaveli prices

The cost for Empaveli subcutaneous solution (1080 mg/20 mL) is around $37,107 for a supply of 160 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

This Empaveli price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.

Subcutaneous Solution

Drugs.com Printable Discount Card

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Empaveli Coupons and Rebates

Empaveli offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Empaveli Apellis Co-Pay Program: Eligible commercially insured patients may receive financial assistance to help cover co-pay and co-insurance costs; for additional information contact the program 866-692-7527.

Applies to:
Empaveli
Number of uses:
Per prescription until program expires

Form more information phone: 866-692-7527 or Visit website

Empaveli Apellis Bridge Program: Eligible commercially insured patients may receive assistance with their prescriptions if experiencing a delay or change in insurance; for additional information contact the program 866-692-7527.

Applies to:
Empaveli
Number of uses:
Temporary Assistance

Form more information phone: 866-692-7527 or Visit website

Patient Assistance Programs for Empaveli

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:
  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. FDA Approved Diagnosis - See Program Website for Details
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
Applicable drugs:
  • Empaveli (pegcetacoplan) Injection; Subcutaneous

More information please phone: 866-316-7263 Visit Website

Provider: ApellisAssist

Elligibility requirements:
  1. Determined case by case
  2. Based on FPL
  3. FDA-approved diagnosis
  4. Must be residing in the US or US territory
  5. Co-payment assistance, patient support, and patient assistance programs are available for eligible patients. Prescribing Physician, Healthcare Facilities, Pharmacies and Patients must enroll into the Risk Evaluation and Mitigation Strategy (REMS) Program prior to initiating the patient on treatment with (Empaveli).
Applicable drugs:
  • Empaveli (pegcetacoplan) Injection; Subcutaneous

More information please phone: 866-692-7527 Visit Website